(Source: Endocrine Web, 29 March 2011)
A medication currently used to treat high blood sugar may help most individuals who are obese and have other metabolic risk factors for type 2 diabetes completely avoid developing the condition. The findings could have implications for millions of Americans.
Dr. Ralph DeFronzo of the University of Texas reported in the New England Journal of Medicine that pioglitazone prevented the progression of pre-diabetes to full-blown diabetes in more than 70 percent of participants who were obese, had a family history of diabetes or had impaired glucose tolerance. Read more
0 comments:
Post a Comment